Skip to main content
TFX
NYSE Industrial Applications And Services

Teleflex Q2 Revenue Surges 29% on VI Business, Guidance Lifted; OEM Sale Closes at $1.5B

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$138.74
Mkt Cap
$6.142B
52W Low
$100.18
52W High
$145
52W Position info
38% above low
Off High info
4.3% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

TFX sits 38% above its 52-week low of $100.18.

Summary

Teleflex Q2 revenue jumped 29% to $570.3M, exceeding estimates, and the company raised guidance. The $1.5B OEM sale closed, a $250M buyback was announced, and a new CEO took the helm amid restructuring progress.


Key Events · Earnings and Guidance · TFX

  • Q2 Revenue +29%, Guidance Raised

    Driven by the VI Business acquisition, net revenues reached $570.3M, surpassing the $559.6M consensus. Strong operational performance led management to raise adjusted EPS guidance.

  • OEM Sale Closed at $1.5B

    The OEM business sale was completed on Aug 3, 2026, delivering $1.5B in net cash proceeds—approximately $1.2B after-tax—with an expected pre-tax gain of roughly $1.0B. Proceeds were used to pay down a $700M term loan.

  • $250M Accelerated Buyback

    During Q2, 1.9M shares were repurchased for $250M at an average price of $130.85. An additional $250M accelerated share repurchase begins Aug 7, 2026, leaving $750M remaining under the $1B authorization.

  • New CEO and Governance Changes

    Jason Weidman assumed the role of President and CEO on June 8, 2026. The filing details his employment, severance, and change-in-control agreements. Meanwhile, activist investor Irenic Capital is pushing for board changes and strategic alternatives.


Analysis · TFX · Industrial Applications And Services

A standout quarter for Teleflex saw revenue climb 29% to $570.3M, fueled by the VI Business acquisition, prompting an upward revision to its adjusted EPS outlook. The $1.5B OEM divestiture closed, delivering roughly $1.2B after-tax, with proceeds earmarked for debt reduction and a $250M accelerated buyback. The period also brought a new CEO, a $25M litigation settlement, and advancing restructuring efforts. While the results and strategic moves point to a company in transformation, activist pressure from Irenic Capital introduces an element of uncertainty.

At the time of this filing, TFX was trading at $138.74 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $100.18 to $145.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TFX - Latest Insights

TFX
Aug 06, 2026, 7:08 AM EDT
Filing Type: 8-K
Importance Score:
8
TFX
Aug 06, 2026, 6:46 AM EDT
Source: Reuters
Importance Score:
8
TFX
Aug 06, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
TFX
Aug 05, 2026, 4:44 PM EDT
Filing Type: 8-K/A
Importance Score:
7
TFX
Aug 03, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
8